Genetic cholestasis syndromes

Journal of Pediatric Gastroenterology and Nutrition

Volumn 28, Issue 2, 1999, Pages 124-131

  Shneider, Benjamin L ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; GAMMA GLUTAMYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN;

ALAGILLE SYNDROME; CHOLESTASIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GENETIC DISORDER; GENETIC LINKAGE; HUMAN; INTRAHEPATIC CHOLESTASIS; MOLECULAR GENETICS; PRIORITY JOURNAL; PRURITUS; REVIEW; SYMPTOMATOLOGY;

ADENOSINE TRIPHOSPHATASES; ALAGILLE SYNDROME; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; CHOLESTASIS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; MEMBRANE GLYCOPROTEINS; MUTATION; P-GLYCOPROTEINS; PEDIATRICS; SYNDROME;

EID: 0033016220     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199902000-00005     Document Type: Review

References (71)

1. Hsia DY, Boggs JD, Driscoll SG, Gellis SS. Prolonged obstructive jaundice in infancy. V. The genetic components in neonatal hepatitis. Amer J Dis Child 1958;485-91.
2. Tygstrup N. Intermittent possibly familial intrahepatic cholestatic jaundice. Lancet 1960;1:1171-2.
3. Danks D, Bodian M. A genetic study of neonatal obstructive jaundice. Arch Dis Child 1963;38:378-90.
4. Cassady G, Morrison AB, Cohen MM. Familial "Giant-cell hepatitis" in infancy. Amer J Dis Child 1964;107:456-69.
5. Smith DW, Opitz JM, Inhorn SL. A syndrome of multiple developmental defects including polycystic kidneys and intrahepatic biliary dysgenesis in 2 siblings. J Pediatr 1965;67:617-24.
6. Clayton RJ, Iber FL, Ruebner BH, Mckusick VA. Byler disease. Fatal familial intrahepatic cholestatis in an Amish kindred. J Pediatr 1965;67:1025-8.
7. Gray OP, Saunders RA. Familial intrahepatic cholestatic jaundice in infancy. Arch Dis Childh 1966;41:320-8.
8. Juberg RC, Holland-Moritz RM, Henley KS, Gonzalez CF. Familial intrahepatic cholestatis with mental and growth retardation. Pediatrics 1966;38:819-6.
9. Strautnieks SS, Kagalwalla AF, Tanner MS, Gardiner RM, Thompson RJ. Locus heterogenity in progressive familial intrahepatic cholestatis. J Med Genet 1996;33:833-6.
10. Bourke B, Goggin N, Walsh D, Kennedy S, Setchell KDR, Drumm B. Byler-like familial cholestatis in an extended kindred. Arch Dis Child 1996;75:223-7.
11. Arnell H, Nemeth A, Anneren G, Dahl N. Progressive familial intrahepatic cholestatis (PFIC): Evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-22. Hum Genet 1997;100:378-81.
12. Riely CA. Familial intrahepatic cholestatic syndromes. Sem Liver Dis 1987;7:119-33.
13. Maggiore G, Bernard O, Riely CA, Hadchouel M, Lemonnier A, Alagille D. Normal serum γ-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestatis with poor prognosis. J Pediatr 1987;111:251-3.
14. 27-steroid dehydrogenase/isomerase deficiency. J Pediatr 1994;125:379-84.
15. Alagille D, Odievre M, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental and sexual development and cardiac murmur. J Pediatr 1975;86:63-71.
16. Riely CA, Cotlier E, Jensen PS, Klatskin G. Arteriohepalic dysplasia: A benign syndrome of intrahepatic cholestatis with multiple organ involvement. Ann Intern Med 1979;91:520-7.
17. Alagille D. Alagille syndrome today. Clin Invest Med 1996;19: 325-30.
18. Byrne JLB, Harrod MJE, Friedman JM, Howard-Peebles PN. Del(20p) with manifestations of arteriohepatic dysplasia. Am J Med Genet 1986;24:673-8.
19. Schnittger S, Hofers C, Heidemann P, Beerman F, Hansmann I. Molecular and cytogenetic analysis of an interstilial 20p deletion associated with syndromic intrahepatic ductular hypoplasia (Alagille syndrome). Hum Genet 1989;83:239-44.
20. Spinner NB, Rand EB, Fortina P, Genin A, Taub R, Semerano A, Piccoli DA. Cytologically balanced t(2;20)in a two generation family with Alagille syndrome: Cytogenetic and molecular studies. Am J Hum Genet 1994;55:238-43.
21. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, Meltzer PS, Spinner NB, Collins FS, Chandrasekharappa SC. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997;16:235-42.
22. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kou WL, Cochran J, Costa T, Pierpont MEM, Rand EB, Piccoli DA, Hood L, Spinner NB. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Nolch1. Nat Genet 1997;16:243-51.
23. Artavanis-Tsakonas S. Alagille syndrome: A notch up for the Notch receptor. Nature Genet 1997;16:212-13.
24. Rand EB. The Genetic Basis of the Alagille Syndrome. J Pediatr Gastroenterol Nutr 1998;26:234-6.
25. Spinner NB, Smith R, Zackai EH, Colliton RP, Genin A, Goldmuntz E, Piccoli DA, Krantz ID. Revised clinical definition of Alagille syndrome based on Jagged1 mutation identificalion [abstract]. J Pediatr Gastroenterol Nutr 1998;26:584.
26. Clayton RJ, Iber FL, Ruebner BH, McKusick VA. Byler Disease: Fatal familial intrahepatic cholestatis in an Amish kindred. Amer J Dis Child 1969;117:112-26.
27. Bull LN, Varlton VEH, Stricker NL, Baharloo S, DeYoung JA, Freimer NB, Magid MS, Kahn E, Markowitz J, DiCarlo FJ, McLoughlin L, Boyle JT, Dahms BB, Faught PR, Fitzgerald JF, Piccoli DA, Witzelben CL, O'Connell NC, Setchell KDR, Agostini RM, Kocoshis SA, Reyes J, Knisely AS. Genetic and Morphological Findings in Progressive Familial Intrahepatic Cholestatis (Byler Disease [PFIC-1] and Byler Syndrome): Evidence for Heterogeneity. Hepatology 1997;26:155-64.
28. Knisely AS, Agostini RM, Zitelli BJ, Kocoshis SA, Boyle JT. Byler's syndrome. Arch Dis Childh 1997;77:276-7.
29. Lloyd-Still JD. Familial cholestatis with elevated sweat electrolyte concentrations. J Pediatr 1981;99:580-3.
30. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestatis. Journal of Pediatric Gastroenterology and Nutrition 1994;18:134-41.
31. Linarelli LG, Williams CN, Phillips MJ. Byler's disease: Fatal intrahepatic cholestatis. J Pediatr 1972;81:484-92.
32. Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestatis. Gastroenterology 1988;95:130-6.
33. Emond JC, Whitington PF. Selective surgical management of progressive intrahepatic cholestatis (Byler's disease). J Pediatr Surg 1995;30:1635-41.
34. Houwen RHJ, Baharloo S, Blankenship K, Raeymaekers P, Juyn J, Sandkuijl LA, Freimer NB. Genome screening by searching fpr shared segments: Mapping a gene for benign recurrent intrahepatic cholestatis. Nature Genet 1994;8:380-6.
35. Carlton VEH, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestatis (Byler's disease) to 18q21-q22, the benign recurrent intrahepatic cholestatis region. Hum Molec Genet 1995;4:1049-53.
36. van Berge Henegouwen GP. Benign recurrent intrahepatic cholestatis and Byler's disease: One gene, two diseases? J Hepatol 1996;25:395-7.
37. Bull LN, vanEijk MJT, Pawlikowska L, DeYoung JA, Juiun J, Liao M, Klomp LWJ, Lomri N, Berger R, Scharschnidt BF, Knisely AS, Houwen RHJ, Freimer NB. Identification of a P-type ATPase mutated in two forms of hereditary cholestasis. Nature Genet 1998;18:219-224.
38. Tang X, Halleck MS, Schlegel RA, Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 1996;272:1495-7.
39. Jacquemin E, Dumont M, Bernard O, Erlinger S, Hadchouel M. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestatis (Byler's disease). European Journal of Pediatrics 1994;153:424-428.
40. Shneider BL. A new era in bile acid transport pathophysiology. J Pediatr Gastroenterol Nutr 1998;26:236-7.
41. Hagenbuch B, Stieger B, Foguet M, Lubbert H, Meier PJ. Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc Natl Acad Sci (USA) 1991; 88:10629-33.
42. Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ. Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proceedings of the National Academy of Sciences of the United States of America 1994;91:133-7.
43. von Dippe P, Amoui M, Stellwagen RH, Levy D. The functional expression of sodium-dependent bile acid transport in Madin-Darby canine kidney cells transfected with the cDNA for microsomal epoxide hydrolase. Journal of Biological Chemistry 1996; 271:18176-80.
44. Stolz A, Hammond L, Lou H, Takikawa H, Ronk M, Shively Je. cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. Journal of Biological Chemistry 1993;268:10448-57.
45. Sippel CJ, Suchy FJ, Ananthanarayanan M, Perlmutter DH. The rat liver ecto-ATPase is also a canalicular bile acid transport protein. Journal of Biological Chemistry 1993;268:2083-91.
46. Adachi Y, Kobayashi H, Kurumi Y, Shouji M, Kitano M, Yamamoto T. ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Hepatology 1991;14:655-659.
47. Nishida T, Gatmaitan Z, Che M, Arias IM. Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. Proceedings of the National Academy of Sciences of the United States of America 1991;88:6590-4.
48. Gerlopff T, Steiger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ. The sister of P-glycoprotein represents the canalicular bile salt export pump of the mammalian liver. J Biol Chem 1998;273:10046-50.
49. Shneider BL, Moyer MS. Characterization of endogenous carrier-mediated taurocholate efflux from Xenopus laevis oocytes. Journal of Biological Chemistry 1993;268:6985-8.
50. Suchy FJ, Sippel CJ, Ananthanarayanan M. Bile acid transport across the hepatocyte canalicular membrane. FASEB J 1997;11: 199-205.
51. Strautnieks SS, Thompson RJ, O'Connell NC, Setchell KDR, Bull LN, Freimer NB, Kocoshis SA, Agostini RM, Knisely AS. Clinical course, histology of the liver, and composition and ultrastructure of bile in progressive familial cholestatis linked to chromosome 2q24. Hepatology 1997;26:606A.
52. Thompson RJ, Strautnieks SS, Kagalwalla AF, Tanner MS, Knisely AS, Bull LN, Freimer NB, Kocoshis SA, Dahl, Arnell H, Sokal E, Gardiner RM. Identification of a second lucos for progressive familial intrahepatic cholestatis on chromosome 2q24. Hepatology 1997;26:383A.
53. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Nemeth A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, Thompson RJ. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nature Genetics 1998;20:233-238.
54. Jansen P, Hooiveld G, Jacquemin E, Sokal E, van Goor H, Koning J, Kuipers F, Stellard F, Hadchouel M, Muller M. The canalicular bile salt exporting protein is not expressed in patients with progressive familial cholestasis type 2 [abstract]. Hepatology 1998;28:498A.
55. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhoff R, van der Lugt NMT, van Roon MA, van der Valk MA, Offerhaus GJA, Berns AJM, Borst P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451-62.
56. Mauad TH, van Nieuwkere CMJ, Dingemans KP, Smit JJM, Schinkel AH, Notenboom RGE, van der Bergh Weerman MA, Verkruisen RP, Groen AK, Oude Elferink RPJ, van der Valk MA, Borst P, Offerhaus GJA. Mice with homozygous disruption of the mdr@ p-glycoprotein gene. A novel animal model for studies of nonsupportive inflammatory cholangitis and hepatocarcinogenesis. American Journal of Pathology 1994;145:1237-45.
57. Nies AT, Gatmaitan Z, Arias IM. ATP-dependent phosphatidyl-choline translocation in rat liver canalicular plasma membrane vesicles. J Lipid Res 1996;37:1125-36.
58. Crawford AR, Smith AJ, Hatch VC, Oude Elferink RPJ, Borst P, Crawford JM. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or mdr3 P-glycoprotein expression. J Clin Invest 1997;100:2562-7.
59. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, Bernard O, Hadchouel M. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996;23:904-8.
60. De Vree JM, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, Deleuze J-F, Desrochers M, Burdelski M, Bernadr O, Oude Elferink RPJ, Hadchoule M. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestatis. Proc Natl Acad Sci USA 1998;95:282-7.
61. Setchell KDR, O'Connell NC. Inborn errors of bile acid metabolism. In: Suchy FJ, ed. Liver Disease in Children. Boston: Mosby, 1994;835-51.
62. Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of the canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-42.
63. Paulusma CC, Kool M, Bosma PJ, Scheffer GL, Ter Borg F, Sheper RJ, Tygat GNJ, Borst P, Baas F, Oude Elferink RPJ. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-42.
64. Jansen PLM, Peters WH, Lamers WH. Heredity chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 1985;573-579.
65. Paulusma CC, Bosma PJ, Zaman GJR, Bakker CTM, Otter M, Scheffer GL, Scheper RJ, Borst P, Oude Elferink RPJ. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996; 271:1126-8.
66. Suchy FJ, Shneider BL. Neonatal jaundice and cholestatis. In: Kaplowitz N, ed. Liver and Bilary Diseases. Philadelphia: Williams and Wilkins, 1996;495-510.
67. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991;14:551-66.
68. Aagenaes O. Hereditary cholestatis with Lymphoedema (Aagenaes syndrome, cholestatis-lymphoedema syndrome). Scand J Gastroenterol 1988;33:335-45.
69. Morton DH, Batta AK, Salen G, Shefer S. Increased serum bile acid concentrations, abnormal hepatocyte bile acid transport and normal histology in 2 Amish families. Gastroenterology 1997;112: A1338.
70. Shneider BL, Fox VL, Schwartz KB, Watson CL, Ananthanarayanan M, thevananther S, Christie DM, Hardikar W, Setchell KDR, Mieli-Vergani G, Suchy FJ, Mowat AP. Hepatic basolateral sodium-dependent bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic bilary atresia. Hepatology 1997;25:1176-83.
71. Zhang X, Arias IM. Deficient MDR3 expression in liver from patients with Navajo neuropathy: A human homologue of mdr2-/-mice. Hepatology 1997;26:369A.